{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:53:48Z","timestamp":1789610028934,"version":"build-2803163510"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.juro.2011.12.062","type":"journal-article","created":{"date-parts":[[2012,3,16]],"date-time":"2012-03-16T23:21:47Z","timestamp":1331940107000},"page":"1890-1897","source":"Crossref","is-referenced-by-count":42,"title":["Suppression of Bladder Overactivity by Adenosine A2A Receptor Antagonist in a Rat Model of Parkinson Disease"],"prefix":"10.1097","volume":"187","author":[{"given":"Takeya","family":"Kitta","sequence":"first","affiliation":[{"name":"Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania"},{"name":"Department of Renal and Genitourinary Surgery, Graduate School of Medicine, Hokkaido University, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Chancellor","sequence":"additional","affiliation":[{"name":"Department of Urology, William Beaumont Hospital, Royal Oak, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"de Groat","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadako","family":"Kuno","sequence":"additional","affiliation":[{"name":"Neuroscience Institute, National Center of Neurology and Psychiatry, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuya","family":"Nonomura","sequence":"additional","affiliation":[{"name":"Department of Renal and Genitourinary Surgery, Graduate School of Medicine, Hokkaido University, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Yoshimura","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania"},{"name":"Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2011.12.062_bib1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1136\/jnnp.68.4.429","article-title":"Assessment of voiding dysfunction in Parkinson's disease by the international prostate symptom score","volume":"68","author":"Araki","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.juro.2011.12.062_bib2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1590\/S0004-282X2003000300007","article-title":"Urinary symptoms in Parkinson's disease: prevalence and associated factors","volume":"61","author":"Campos Sousa","year":"2003","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.juro.2011.12.062_bib3","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0140-6736(88)90932-4","article-title":"Role of subcutaneous apomorphine in parkinsonian voiding dysfunction","volume":"2","author":"Christmas","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.juro.2011.12.062_bib4","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/mds.20867","article-title":"Bladder dysfunction in Parkinsonism: mechanisms, prevalence, symptoms, and management","volume":"21","author":"Winge","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.juro.2011.12.062_bib5","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/nau.20054","article-title":"Effects of dopaminergic treatment on bladder function in Parkinson's disease","volume":"23","author":"Winge","year":"2004","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.juro.2011.12.062_bib6","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1056\/NEJM200005183422004","article-title":"A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa","volume":"342","author":"Rascol","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2011.12.062_bib7","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1016\/j.lfs.2005.04.029","article-title":"New therapies for the treatment of Parkinson's disease: adenosine A2A receptor antagonists","volume":"77","author":"Pinna","year":"2005","journal-title":"Life Sci"},{"key":"10.1016\/j.juro.2011.12.062_bib8","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.tins.2006.09.004","article-title":"Targeting adenosine A2A receptors in Parkinson's disease","volume":"29","author":"Schwarzschild","year":"2006","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.juro.2011.12.062_bib9","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0022-3565(24)37579-2","article-title":"Therapeutic effects of dopamine D1\/D2 receptor agonists on detrusor hyperreflexia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian cynomolgus monkeys","volume":"286","author":"Yoshimura","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.juro.2011.12.062_bib10","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/1520-6777(2001)20:1<105::AID-NAU12>3.0.CO;2-9","article-title":"Role of dopamine D1 and D2 receptors in the micturition reflex in conscious rats","volume":"20","author":"Seki","year":"2001","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.juro.2011.12.062_bib11","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1111\/j.1460-9568.2008.06276.x","article-title":"GABAergic mechanism mediated via D receptors in the rat periaqueductal gray participates in the micturition reflex: an in vivo microdialysis study","volume":"27","author":"Kitta","year":"2008","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.juro.2011.12.062_bib12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0028-3908(93)90151-R","article-title":"The dopamine D1 receptor agonist SKF 38393 suppresses detrusor hyperreflexia in the monkey with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)","volume":"32","author":"Yoshimura","year":"1993","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.juro.2011.12.062_bib13","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/sj.bjp.0705388","article-title":"Dopaminergic mechanisms underlying bladder hyperactivity in rats with a unilateral 6-hydroxydopamine (6-OHDA) lesion of the nigrostriatal pathway","volume":"139","author":"Yoshimura","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.juro.2011.12.062_bib14","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S1566-0702(01)00295-8","article-title":"Questionnaire-based assessment of pelvic organ dysfunction in Parkinson's disease","volume":"92","author":"Sakakibara","year":"2001","journal-title":"Auton Neurosci"},{"key":"10.1016\/j.juro.2011.12.062_bib15","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson's disease: diagnosis and management","volume":"5","author":"Chaudhuri","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.juro.2011.12.062_bib16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/nau.1930120302","article-title":"Effects of apomorphine and L-dopa on the parkinsonian bladder","volume":"12","author":"Aranda","year":"1993","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.juro.2011.12.062_bib17","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/S0022-5347(05)67048-6","article-title":"Voiding dysfunction and Parkinson's disease: urodynamic abnormalities and urinary symptoms","volume":"164","author":"Araki","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2011.12.062_bib18","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1468-1331.2005.01087.x","article-title":"Relationship between nigrostriatal dopaminergic degeneration, urinary symptoms, and bladder control in Parkinson's disease","volume":"12","author":"Winge","year":"2005","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.juro.2011.12.062_bib19","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/0304-3940(88)90143-7","article-title":"Bladder hyperreflexia induced in marmosets by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"87","author":"Albanese","year":"1988","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.juro.2011.12.062_bib20","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1006\/exnr.2001.7639","article-title":"Interaction between D2 dopaminergic and glutamatergic excitatory influences on lower urinary tract function in normal and cerebral-infarcted rats","volume":"169","author":"Yokoyama","year":"2001","journal-title":"Exp Neurol"},{"key":"10.1016\/j.juro.2011.12.062_bib21","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0022-5347(05)00058-3","article-title":"Central acute D2 stimulation worsens bladder function in patients with mild Parkinson's disease","volume":"175","author":"Brusa","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2011.12.062_bib22","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1002\/mds.22840","article-title":"Comparing bromocriptine effects with levodopa effects on bladder function in Parkinson's disease","volume":"24","author":"Uchiyama","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.juro.2011.12.062_bib23","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0031-6997(24)01511-4","article-title":"International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors","volume":"53","author":"Fredholm","year":"2001","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.juro.2011.12.062_bib24","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.pneurobio.2007.05.001","article-title":"Adenosine A2A receptors and basal ganglia physiology","volume":"83","author":"Schiffmann","year":"2007","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.juro.2011.12.062_bib25","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.2174\/138161208784480108","article-title":"An update on adenosine A2A-dopamine D2 receptor interactions: implications for the function of G protein-coupled receptors","volume":"14","author":"Ferre","year":"2008","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.juro.2011.12.062_bib26","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1365-2680.1998.1820099.x","article-title":"Effect of exogenous adenosine and its monophosphate on the contractile response to acetylcholine in the human isolated detrusor muscle strips","volume":"18","author":"Rubinstein","year":"1998","journal-title":"J Auton Pharmacol"},{"key":"10.1016\/j.juro.2011.12.062_bib27","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/brain\/awh128","article-title":"Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesias","volume":"127","author":"Calon","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.juro.2011.12.062_bib28","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00002826-199712000-00004","article-title":"Motor complications of chronic levodopa therapy in Parkinson's disease","volume":"20","author":"Miyawaki","year":"1997","journal-title":"Clin Neuropharmacol"},{"issue":"suppl.","key":"10.1016\/j.juro.2011.12.062_bib29","first-page":"S72","article-title":"Pulsatile stimulation of dopamine receptors and levodopa-induced motor complications in Parkinson's disease: implications for the early use of COMT inhibitors","volume":"55","author":"Olanow","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.juro.2011.12.062_bib30","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/mds.10403","article-title":"Short-term effect of a single levodopa dose on micturition disturbance in Parkinson's disease patients with the wearing-off phenomenon","volume":"18","author":"Uchiyama","year":"2003","journal-title":"Mov Disord"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534711060095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534711060095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2011.12.062","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T16:27:31Z","timestamp":1784910451000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1016\/j.juro.2011.12.062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["10.1016\/j.juro.2011.12.062"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2011.12.062","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.14263971.15777063","asserted-by":"object"}]},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}